TY - JOUR
T1 - Acute-onset paralytic strabismus in toddlers is important to consider as a potential early sign of late-infantile Metachromatic Leukodystrophy
AU - Beerepoot, Shanice
AU - Wolf, Nicole I.
AU - Wehner, Katharina
AU - Bender, Benjamin
AU - van der Knaap, Marjo S.
AU - Krägeloh-Mann, Ingeborg
AU - Groeschel, Samuel
N1 - © 2022 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.
PY - 2022/3
Y1 - 2022/3
N2 - Objectives: Metachromatic leukodystrophy (MLD) is a fatal lysosomal storage disease characterized by progressive demyelination within the central and peripheral nervous system. Rapid diagnosis is crucial in view of evolving therapeutic options. Strabismus has anecdotally been described as a feature in children with MLD. Our first aim was to examine the prevalence of strabismus as an early or even presenting sign of MLD in two nationwide cohorts. Second, we aimed to investigate the temporal relation between the onset of strabismus and gross motor deterioration, other early onset eye movement disorders and brain white matter abnormalities. Methods: Clinical records of 204 MLD patients at the University Children's Hospital Tubingen and Amsterdam University Medical Center were reviewed on the presence of strabismus and other eye movement disorders. Gross motor deterioration and white matter abnormalities on brain MRI were evaluated by using the Gross Motor Function Classification in MLD and MLD LOES score, respectively. Results: We identified strabismus as an early sign in MLD patients with the late-infantile form, with a prevalence of 27% (N = 17). The onset of strabismus preceded gross motor symptoms and brain white matter abnormalities in 71% and 46% respectively of the cases. Important characteristics were an acute-onset paralytic esotropia, partly accompanied by other eye movement abnormalities, and gadolinium enhancement of the cranial nerves. Conclusions: Acute-onset paralytic strabismus in toddlers should be considered a potential early sign of late-infantile MLD and might result from early cranial nerve involvement. Brain MRI with gadolinium contrast may facilitate early diagnosis.
AB - Objectives: Metachromatic leukodystrophy (MLD) is a fatal lysosomal storage disease characterized by progressive demyelination within the central and peripheral nervous system. Rapid diagnosis is crucial in view of evolving therapeutic options. Strabismus has anecdotally been described as a feature in children with MLD. Our first aim was to examine the prevalence of strabismus as an early or even presenting sign of MLD in two nationwide cohorts. Second, we aimed to investigate the temporal relation between the onset of strabismus and gross motor deterioration, other early onset eye movement disorders and brain white matter abnormalities. Methods: Clinical records of 204 MLD patients at the University Children's Hospital Tubingen and Amsterdam University Medical Center were reviewed on the presence of strabismus and other eye movement disorders. Gross motor deterioration and white matter abnormalities on brain MRI were evaluated by using the Gross Motor Function Classification in MLD and MLD LOES score, respectively. Results: We identified strabismus as an early sign in MLD patients with the late-infantile form, with a prevalence of 27% (N = 17). The onset of strabismus preceded gross motor symptoms and brain white matter abnormalities in 71% and 46% respectively of the cases. Important characteristics were an acute-onset paralytic esotropia, partly accompanied by other eye movement abnormalities, and gadolinium enhancement of the cranial nerves. Conclusions: Acute-onset paralytic strabismus in toddlers should be considered a potential early sign of late-infantile MLD and might result from early cranial nerve involvement. Brain MRI with gadolinium contrast may facilitate early diagnosis.
KW - Arylsulfatase A deficiency
KW - Cellular therapies
KW - Cranial nerves
KW - Esotropia
KW - Lysosomal storage disorder
KW - Magnetic Resonance Imaging
KW - Strabismus/diagnosis
KW - Humans
KW - Contrast Media/therapeutic use
KW - Leukodystrophy, Metachromatic/diagnosis
KW - Gadolinium/therapeutic use
UR - http://www.scopus.com/inward/record.url?scp=85124237796&partnerID=8YFLogxK
U2 - 10.1016/j.ejpn.2022.01.020
DO - 10.1016/j.ejpn.2022.01.020
M3 - Article
C2 - 35152000
AN - SCOPUS:85124237796
SN - 1090-3798
VL - 37
SP - 87
EP - 93
JO - European Journal of Paediatric Neurology
JF - European Journal of Paediatric Neurology
ER -